Company intelligence / Profile preview

Institute Medicinal Cannabis

Glil Yam, Israel

Ownership: Private
Employees: ~150
Development stage: Other

Overview

IM Cannabis Corp. (IMC) is an international medical cannabis company with operations in Israel, Germany, and Canada. The company focuses on providing premium medical-grade cannabis products to patients and pharmacies through a data-driven cultivation and distribution network. IMC leverages its proprietary genetics and global supply chain to deliver standardized cannabinoid-based therapies for various medical indications. As a leading multi-country operator, the company is strategically positioned to capitalize on the evolving regulatory landscape of the global medical cannabis market.

Therapeutic areas: PsychiatryNeurologyGastroenterology
Modalities: Small moleculePlant-derived extract
Industry: Biotech

Partnerships

OrganigramThe Flowr Corporation

Beyond the preview

Go deeper on Institute Medicinal Cannabis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Institute Medicinal Cannabis.

Explore the full profile